Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2016 · second_quarter · Q2
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Source: Senate LDA
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Calling for Sickle Cell Trait research.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Making further continuing appropriations for fiscal year 2016, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Bipartisan Budget Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600)
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Consolidated Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Further Continuing Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 *(H.R. 3020/S. 1695)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6)
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative regulation of laboratory developed tests
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
Continuing Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Calling for Sickle Cell Trait research.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6)
Calling for Sickle Cell Trait research.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative regulation of laboratory developed tests
Calling for Sickle Cell Trait research.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 *(H.R. 3020/S. 1695)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Continuing Appropriations Resolution, 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention; Public Health Program Funding; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; Continuing Appropriations Resolution, 2015 (H.J.Res. 124)
Making further continuing appropriations for fiscal year 2015, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, 2015 FY 2015 Continuing Resolution (through December 13, 2014)(H.J.Res. 130) FY 2015 Continuing Resolution (through December 17, 2014)(H.J.Res. 131) FY 2015 Omnibus, Consolidated and Further Continuing Appropriations Act (H.R. 83)
Making further continuing appropriations for fiscal year 2015, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, 2015 FY 2015 Continuing Resolution (through December 13, 2014)(H.J.Res. 130) FY 2015 Continuing Resolution (through December 17, 2014)(H.J.Res. 131) FY 2015 Omnibus, Consolidated and Further Continuing Appropriations Act (H.R. 83)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Cancer Drug Coverage Parity Act (H.R. 1801) Cancer Treatment Parity Act (S. 1879) Patients' Access to Treatments Act (H.R. 460)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implimentation of The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879)
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act(P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
Protecting Access to Medicare Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
Protecting Access to Medicare Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
Protecting Access to Medicare Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act(P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Protecting Access to Medicare Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
Patients' Access to Treatments Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Patients' Access to Treatments Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Patients' Access to Treatments Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Cancer Drug Coverage Parity Act (H.R. 1801) Cancer Treatment Parity Act (S. 1879) Patients' Access to Treatments Act (H.R. 460)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2014 and FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014 (S. 1284) FY 2014 Consolidated Appropriations Act (H.R. 3547)
Cancer Treatment Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Cancer Drug Coverage Parity Act (H.R. 1801) Cancer Treatment Parity Act (S. 1879) Patients' Access to Treatments Act (H.R. 460)
Cancer Treatment Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implimentation of The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879)
Cancer Treatment Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Cancer Treatment Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act(P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage Cancer Drug Coverage Parity Act (H.R. 1801)Cancer Drug Coverage Parity Act (H.R. 1801)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage; Cancer Drug Coverage Parity Act (H.R. 1801)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801)
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2014 Funding for the National Institutes of Health Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014 (S. 1284) FY 2014 Continuing Resolution (H.J.Res. 59)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2014 Funding for the National Institutes of Health Public Health Program Funding Department of Labor, Health and Humans Services, and Education, and Related Agencies Appropriations Act, 2014 (s. 1284) FY 2014 Continuing Resolution H.J.Res 59)
American Taxpayer Relief Act of 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2013 Funding for the National Institutes of Health Public Health Program Funding H.R. 933, Consolidated and Further Continuing Appropriations Act, 2013 H.R. 8, American Taxpayer Relief Act of 2012
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease/Trait Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act H.R. 3433, the Grant Reform and New Transparency Act Hematology workforce issues
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act Hematology workforce issues Clinical Trials
Thrombosis Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine H.R. 3433, the Grant Reform and New Transparency Act
Thrombosis Sickle Cell Disease/Trait Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine H.R. 3433, the Grant Reform and New Transparency Act
Thrombosis Sickle Cell Disease/Trait Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act H.R. 3433, the Grant Reform and New Transparency Act Hematology workforce issues
Drug Shortage Prevention Act of 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act Hematology workforce issues Clinical Trials
Drug Shortage Prevention Act of 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease/Trait Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act H.R. 3433, the Grant Reform and New Transparency Act Hematology workforce issues
American Taxpayer Relief Act of 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2013 Funding for the National Institutes of Health Public Health Program Funding S. 3295, Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2013 H.R. 8, American Taxpayer Relief Act of 2012
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act Hematology workforce issues
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2016 · first_quarter · Q1
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2015 · fourth_quarter · Q4
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2015 · third_quarter · Q3
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative regulation of laboratory developed tests
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2015 · second_quarter · Q2
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6)
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 *(H.R. 3020/S. 1695)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2015 · first_quarter · Q1
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2014 · fourth_quarter · Q4
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act(P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Cancer Drug Coverage Parity Act (H.R. 1801) Cancer Treatment Parity Act (S. 1879) Patients' Access to Treatments Act (H.R. 460)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2014 · third_quarter · Q3
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention; Public Health Program Funding; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; Continuing Appropriations Resolution, 2015 (H.J.Res. 124)
Sickle Cell Disease/Trait; Hematology/Oncology Treatment Issues; General Hematology Public Health and Research Issues
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2014 · second_quarter · Q2
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2014 · first_quarter · Q1
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
FY 2014 and FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014 (S. 1284) FY 2014 Consolidated Appropriations Act (H.R. 3547)
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implimentation of The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2013 · fourth_quarter · Q4
FY 2014 Funding for the National Institutes of Health Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014 (S. 1284) FY 2014 Continuing Resolution (H.J.Res. 59)
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2013 · third_quarter · Q3
FY 2014 Funding for the National Institutes of Health Public Health Program Funding Department of Labor, Health and Humans Services, and Education, and Related Agencies Appropriations Act, 2014 (s. 1284) FY 2014 Continuing Resolution H.J.Res 59)
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2013 · second_quarter · Q2
Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage Cancer Drug Coverage Parity Act (H.R. 1801)Cancer Drug Coverage Parity Act (H.R. 1801)
FY 2014 Funding for the National Institutes of Health Public Health Program Funding
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2013 · first_quarter · Q1
FY 2013 Funding for the National Institutes of Health Public Health Program Funding H.R. 933, Consolidated and Further Continuing Appropriations Act, 2013 H.R. 8, American Taxpayer Relief Act of 2012
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage
Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2012 · fourth_quarter · Q4
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage
FY 2013 Funding for the National Institutes of Health Public Health Program Funding S. 3295, Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2013 H.R. 8, American Taxpayer Relief Act of 2012
Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2012 · third_quarter · Q3
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures CMS Strategic Priorities Clinical Trials Regulations Electronic Health Records (EHR)
Thrombosis Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine H.R. 3433, the Grant Reform and New Transparency Act
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2012 · second_quarter · Q2
FY 2013 Funding for the National Institutes of Health Public Health Program Funding
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act Hematology workforce issues Clinical Trials
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures CMS Strategic Priorities Clinical Trials Regulations Electronic Health Records (EHR)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2012 · first_quarter · Q1
Thrombosis Sickle Cell Disease/Trait Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act H.R. 3433, the Grant Reform and New Transparency Act Hematology workforce issues
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies (H.R. 3630, the Middle Class Tax Relief and Job creation Act of 2012) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2011 · fourth_quarter · Q4
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
FY 2012 Funding for the National Institutes of Health Public Health Program Funding Budget Control Act of 2011 (S. 365) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 (S. 1599/H.R. 3070) Consolidated Appropriations Act, 2012 (H.R. 3671)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2011 · third_quarter · Q3
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
FY 2012 Funding for the National Institutes of Health Public Health Program Funding Budget Control Act of 2011 (S. 365) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 (S. 1599/H.R. 3070)
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2011 · second_quarter · Q2
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act S.Res. 172, resolution designating May 2011 as National Cancer Research Month
FY 2011 and FY 2012 Funding for the National Institutes of Health Public Health Program Funding H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act, 2011
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2011 · first_quarter · Q1
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues Embryonic Stem Cell Research and Regenerative Medicine Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research S. 296, the Preserving Access to Life-Saving Medications Act
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2010 · fourth_quarter · Q4
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Medicare and Medicaid Extenders Act of 2010 (H.R. 4994) Physician Payment and Therapy Relief Act of 2010 (H.R. 5712) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting Initiative (PQRS) Measures Electronic Health Records CMS Strategic Priorities
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2010 · third_quarter · Q3
Funding for the National Institutes of Health Public Health Program Funding House and Senate (S. 3686) FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2010 · second_quarter · Q2
Implementation of Health Reform Legislation / Patient Protection and Afforadable Care Act (H.R. 3590 / P.L. 111-148)
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Continuing Extension Act of 2010 (H.R. 4851) / American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213) / PAID FOR Temporary Extension Act of 2010 (S. 3421) / Preservation of Access to Care for Medicare Beneficaries and Pension Relief Act of 2010 (H.R. 3962) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (H.R. 3590 / P.L. 111-148)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2010 · first_quarter · Q1
Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Funding for the National Institutes of Health House and Senate FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills Public Health Program Funding
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2009 · fourth_quarter · Q4
Funding for the National Institutes of Health House and Senate FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills (H.R.3293) Public Health Program Funding House and Senate FY 2010 Department of Defense Appropriations Bill (H.R.3326)
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2009 · third_quarter · Q3
Funding for the National Institutes of Health House and Senate FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills (H.R.3293) Public Health Program Funding House and Senate FY 2010 Department of Defense Appropriations Bill (H.R.3326)
Stem Cell Research Enhancement Act (H.R.873/S.487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R.1230) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679) Physician Payments Sunshine Act (S.301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2009 · second_quarter · Q2
Funding for the National Institutes of Health FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills Public Health Program Funding FY 2010 Department of Defense Appropriations bill
Stem Cell Research Enhancement Act (H.R. 873/S. 487); Embryonic Stem Cell Research; Somatic Cell Nuclear Transfer; Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research Health Reform Legislation
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2009 · first_quarter · Q1
Funding for the National Institutes of Health American Recovery and Reinvestment Act of 2009 (H.R. 1) FY 2009 Omnibus Appropriations Act (H.R. 1105) FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act Public Health Program Funding FY 2010 Department of Defense Appropriations Act
Stem Cell Research Enhancement Act (H.R. 873/S. 487), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources and Radioisotopes in Biomedical Research
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2008 · fourth_quarter · Q4
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Security and Continued Use of Cesium-137 Chloride Sources in Biomedical Research
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2008 · third_quarter · Q3
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Genetic Information Nondiscrimination Act (S. 358/H.R. 493) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Security and Continued Use of Cesium-137 Chloride Sources in Biomedical Research
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, 2015 FY 2015 Continuing Resolution (through December 13, 2014)(H.J.Res. 130) FY 2015 Continuing Resolution (through December 17, 2014)(H.J.Res. 131) FY 2015 Omnibus, Consolidated and Further Continuing Appropriations Act (H.R. 83)
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention; Public Health Program Funding; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015
Sickle Cell Disease/Trait; Hematology/Oncology Treatment Issues; General Hematology Public Health and Research Issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage; Cancer Drug Coverage Parity Act (H.R. 1801)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Hematology workforce issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage
FY 2013 Funding for the National Institutes of Health Public Health Program Funding S. 3295, Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2013
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Thrombosis Sickle Cell Disease/Trait Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine H.R. 3433, the Grant Reform and New Transparency Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
FY 2013 Funding for the National Institutes of Health Public Health Program Funding
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act Hematology workforce issues
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act Hematology workforce issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
FY 2011 and FY 2012 Funding for the National Institutes of Health Public Health Program Funding H.R. 1, the 2011 Full-Year Continuing Appropriations Act
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Medicare Advantage Coverage of Routine Costs for Clinical Trials Participants Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance and Portability Act
Continuing Appropriations and Surface Transportation Extensions Act, 2011 (H.R. 3082) Funding for the National Institutes of Health Public Health Program Funding House and Senate FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance and Portability Act
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Electronic Health Records Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS Strategic Priorities Physician Quality Reporting Initiative (PQRI) Measures
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Funding for the National Institutes of Health House and Senate FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills Public Health Program Funding
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Electronic Prescription for Controlled Substances
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), President of the U.S., SENATE